Hypothalamic–pituitary–bone marrow axis promotes tumor-induced immunosuppression

Yueli Xu; Jiaxian Yan; Rongbin Zhou

doi:10.1093/lifemedi/lnac058

Life Medicine ›› 2023, Vol. 2 ›› Issue (1) : 4 DOI: 10.1093/lifemedi/lnac058

Research Highlight

Hypothalamic–pituitary–bone marrow axis promotes tumor-induced immunosuppression

Author information +

History +

PDF (186KB)

Cite this article

Download citation ▾

Yueli Xu, Jiaxian Yan, Rongbin Zhou. Hypothalamic–pituitary–bone marrow axis promotes tumor-induced immunosuppression. Life Medicine, 2023, 2(1): 4 DOI:10.1093/lifemedi/lnac058

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Wang H, Zheng Q, Lu Z, et al. Role of the nervous system in cancers: a review. Cell Death Discov 2021;7:76.

[2]	Jiang X, Wang J, Deng X, et al. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. Mol Cancer 2019;18:10.

[3]	Yang H, Xia L, Chen J, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med 2019;25:1428–41.

[4]	Chakraborty B, Byemerwa J, Shepherd J, et al. Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma. J Clin Invest 2021;131:e151347.

[5]	Hong JY, Lim J, Carvalho F, et al. Long-term programming of CD8 T cell immunity by perinatal exposure to glucocorticoids. Cell 2020;180:847–61.

[6]	Özdemir BC, Dotto GP. Sex hormones and anticancer immunity. Clin Cancer Res 2019;25:4603–10.

[7]	Yang C, Jin J, Yang Y, et al. Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity. Immunity 2022;55:1268–83.